Corporate News     16-Apr-21
Vivimed Labs receives approval for 3 products from its Hyderabad site
Vivimed Labs announced today that it received approvals for 3 products from its state of the art manufacturing site in Hyderabad, which is PICS & Health Canada approved site.

1. Bilastine tablets 20mg under brand name FLUSTIN
2. Ornidazole and Otloxacin tablets under brand name ORZOLE COMBI
3. Paracetamol 12Smg/Sml and Chlorpheniramine Maleate Syrup 2mg/Sml 100mi under brand name FEBRIL

Previous News
  Vivimed Labs AGM scheduled
 ( Corporate News - 16-Aug-19   17:16 )
  Vivimed Labs soars after Jeedimetla facility gets Ukraine GMP approval
 ( Hot Pursuit - 04-Mar-21   14:00 )
  Vivimed Labs to hold AGM
 ( Corporate News - 14-Jan-23   14:52 )
  Vivimed Labs receives Ukraine GMP approval for Jeedimetla facility
 ( Corporate News - 04-Mar-21   18:38 )
  Lupin Ltd Slides 4.3%
 ( Hot Pursuit - 16-May-19   09:45 )
  Vivimed Labs Ltd leads losers in 'B' group
 ( Hot Pursuit - 23-Feb-21   14:46 )
  Vivimed Labs consolidated net profit declines 29.75% in the March 2016 quarter
 ( Results - Announcements 01-Jun-16   09:29 )
  Vivimed Labs jumps on plan to divest part of specialty chemicals division
 ( Hot Pursuit - 30-Sep-15   14:31 )
  Vivimed Labs to hold board meeting
 ( Corporate News - 01-Aug-16   11:15 )
  Vivimed Labs to conduct AGM
 ( Corporate News - 04-Sep-17   12:10 )
  Vivimed Labs signs definitive agreement for transfer & sale of products
 ( Corporate News - 30-Sep-15   09:58 )
Other Stories
  PVV Infra to convene board meeting
  05-Oct-24   10:06
  Avenue Supermarts declare Quarterly Result
  05-Oct-24   10:06
  Fortis Healthcare to hold board meeting
  05-Oct-24   10:06
  Syngene International to convene board meeting
  05-Oct-24   10:06
  Srestha Finvest to conduct board meeting
  05-Oct-24   10:06
  Spright Agro schedules board meeting
  05-Oct-24   10:05
  Jagsonpal Finance & Leasing to table results
  05-Oct-24   10:05
  Hathway Cable & Datacom to hold board meeting
  05-Oct-24   10:05
  Bajaj Housing Finance to announce Quarterly Result
  05-Oct-24   10:05
  Board of NRB Bearings recommends interim dividend
  05-Oct-24   09:27
Back Top